CD19 and Splenomegaly: In elderly AiolosCd19-L161R mice (18–24 months of age), 10% of AiolosCd19-L161R/Cd19-L161R and 36% of Aiolos+/Cd19-L161R mice developed CLL-like disease and occasional splenomegaly.